[Skip to Content]
[Skip to Content Landing]

Screening for Depression and Suicide Risk in Children and AdolescentsUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force

To identify the key insights or developments described in this article
1 Credit CME
Abstract

Importance  Depression, suicidal ideation, and self-harm behaviors in youth are associated with functional impairment and suicide.

Objective  To review the evidence on screening for depression or suicide risk in children and adolescents to inform the US Preventive Services Task Force (USPSTF).

Data Sources  PubMed, Cochrane Library, PsycINFO, CINAHL, and trial registries through July 19, 2021; references, experts, and surveillance through June 1, 2022.

Study Selection  English-language, randomized clinical trials (RCTs) of screening for depression or suicide risk; diagnostic test accuracy studies; RCTs of psychotherapy and first-line pharmacotherapy; RCTs, observational studies, and systematic reviews reporting harms.

Data Extraction and Synthesis  Two reviewers assessed titles/abstracts, full-text articles, and study quality and extracted data; when at least 3 similar studies were available, meta-analyses were conducted.

Main Outcomes and Measures  Test accuracy, symptoms, response, remission, loss of diagnosis, mortality, functioning, suicide-related events, and adverse events.

Results  Twenty-one studies (N = 5433) were included for depression and 19 studies (N = 6290) for suicide risk. For depression, no studies reported on the direct effects of screening on health outcomes, and 7 studies (n = 3281) reported sensitivity of screening instruments ranging from 0.59 to 0.94 and specificity from 0.38 to 0.96. Depression treatment with psychotherapy was associated with improved symptoms (Beck Depression Inventory pooled standardized mean difference, −0.58 [95% CI, −0.83 to −0.34]; n = 471; 4 studies; and Hamilton Depression Scale pooled mean difference, −2.25 [95% CI, −4.09 to −0.41]; n = 262; 3 studies) clinical response (3 studies with statistically significant results using varying thresholds), and loss of diagnosis (relative risk, 1.73 [95% CI, 1.00 to 3.00; n = 395; 4 studies). Pharmacotherapy was associated with improvement on symptoms (Children’s Depression Rating Scale–Revised mean difference, −3.76 [95% CI, −5.95 to −1.57; n = 793; 3 studies), remission (relative risk, 1.20 [95% CI, 1.00 to 1.45]; n = 793; 3 studies) and functioning (Children’s Global Assessment Scale pooled mean difference, 2.60 (95% CI, 0.78 to 4.42; n = 793; 3 studies). Other outcomes were not statistically significantly different. Differences in suicide-related outcomes and adverse events for pharmacotherapy when compared with placebo were not statistically significant. For suicide risk, no studies reported on the direct benefits of screening on health outcomes, and 2 RCTs (n = 2675) reported no harms of screening. One study (n = 581) reported on sensitivity of screening, ranging from 0.87 to 0.91; specificity was 0.60. Sixteen RCTs (n = 3034) reported on suicide risk interventions. Interventions were associated with lower scores for the Beck Hopelessness Scale (pooled mean difference, −2.35 [95% CI, −4.06 to −0.65]; n = 644; 4 RCTs). Findings for other suicide-related outcomes were mixed or not statistically significantly different.

Conclusion and Relevance  Indirect evidence suggested that some screening instruments were reasonably accurate for detecting depression. Psychotherapy and pharmacotherapy were associated with some benefits and no statistically significant harms for depression, but the evidence was limited for suicide risk screening instruments and interventions.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Meera Viswanathan, PhD, RTI International, 3040 E Cornwallis Rd, Research Triangle Park, NC 27709 (viswanathan@rti.org).

Accepted for Publication: August 25, 2022.

Published Online: October 11, 2022. doi:10.1001/jama.2022.16310

Author Contributions: Dr Viswanathan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Viswanathan, Kahwati.

Acquisition, analysis, or interpretation of data: Viswanathan, Wallace, Cook Middleton, Kennedy, McKeeman, Hudson, Rains, Vander Schaaf.

Drafting of the manuscript: Viswanathan, Kennedy, Rains.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Viswanathan, Wallace, Kahwati.

Obtained funding: Viswanathan, Kahwati.

Administrative, technical, or material support: Viswanathan, Kennedy, Rains.

Supervision: Viswanathan.

Conflict of Interest Disclosures: Dr Vander Schaaf reported that she is a Fellow of the American Academy of Pediatrics and member of American Academy of Pediatrics CATCH Committee. No other disclosures were reported.

Funding/Support: This study was funded under contract HHSA-290-2015-00011-I, Task Order 15, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (HHS), under a contract to support the US Preventive Services Task Force (USPSTF).

Role of the Funder/Sponsor: Investigators worked with USPSTF members and AHRQ staff to develop the scope, analytic framework, and key questions for this review. AHRQ had no role in study selection, quality assessment, or synthesis. AHRQ staff provided project oversight, reviewed the report to ensure that the analysis met methodological standards, and distributed the draft for peer review. Otherwise, AHRQ had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript findings. The opinions expressed in this document are those of the authors and do not represent the official position of AHRQ or HHS.

Additional Contributions: We acknowledge the following individuals for their contributions to this project: AHRQ staff Iris Mabry-Hernandez, MD, MPH, and Tracy Wolf, MD, MPH; current and former members of the USPSTF who contributed to topic deliberations; RTI International–University of North Carolina Evidence-based Practice Center staff Christiane Voisin, MSLS, Candi Wines, MPH, Nila A. Sathe, MA, MLIS, Carol Woodell, BSPH, Sharon Barrell, MA, Staci Rachman, BA, Michelle Bogus, Sarah Barringer, and Loraine Monroe. USPSTF members, peer reviewers, and federal partner reviewers did not receive financial compensation for their contributions.

Additional Information: A draft version of the full evidence report underwent external peer review from 4 content experts (Gregory Simon, MD, MPH, University of Washington; Joan Asarnow, PhD, University of California, Los Angeles; Natalie Cort, PhD, William James College; and Raquel Halfond, PhD, American Psychological Association) and a federal partner reviewer (Erin Abramsohn, DrPH, MPH, Centers for Disease Control and Prevention). Comments from reviewers were presented to the USPSTF during its deliberation of the evidence and were considered in preparing the final evidence review.

Editorial Disclaimer: This evidence report is presented as a document in support of the accompanying USPSTF recommendation statement. It did not undergo additional peer review after submission to JAMA.

References
1.
Wilson  S , Hicks  BM , Foster  KT , McGue  M , Iacono  WG .  Age of onset and course of major depressive disorder: associations with psychosocial functioning outcomes in adulthood.   Psychol Med. 2015;45(3):505-514. doi:10.1017/S0033291714001640PubMedGoogle ScholarCrossref
2.
Whalen  DJ , Dixon-Gordon  K , Belden  AC , Barch  D , Luby  JL .  Correlates and consequences of suicidal cognitions and behaviors in children ages 3 to 7 years.   J Am Acad Child Adolesc Psychiatry. 2015;54(11):926-37. doi:10.1016/j.jaac.2015.08.009PubMedGoogle ScholarCrossref
3.
Melvin  GA , Dudley  AL , Gordon  MS , Ford  S , Taffe  J , Tonge  BJ .  What happens to depressed adolescents? a follow-up study into early adulthood.   J Affect Disord. 2013;151(1):298-305. doi:10.1016/j.jad.2013.06.012PubMedGoogle ScholarCrossref
4.
Leone  M , Kuja-Halkola  R , Leval  A ,  et al.  Association of youth depression with subsequent somatic diseases and premature death.   JAMA Psychiatry. 2021;78(3):302-310. doi:10.1001/jamapsychiatry.2020.3786PubMedGoogle ScholarCrossref
5.
Siu  AL ; US Preventive Services Task Force.  Screening for depression in children and adolescents: US Preventive Services Task Force recommendation statement.   Ann Intern Med. 2016;164(5):360-366. doi:10.7326/M15-2957PubMedGoogle ScholarCrossref
6.
LeFevre  ML ; US Preventive Services Task Force.  Screening for suicide risk in adolescents, adults, and older adults in primary care: US Preventive Services Task Force recommendation statement.   Ann Intern Med. 2014;160(10):719-726. doi:10.7326/M14-0589PubMedGoogle ScholarCrossref
7.
US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Published 2021. Accessed August 16, 2022. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual
8.
Viswanathan  M , Wallace  I , Cook Middleton  J ,  et al.  Screening for Depression, Anxiety, and Suicide Risk in Children and Adolescents: An Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 221. Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05293-EF-1.
9.
Forman-Hoffman  V , McClure  E , McKeeman  J ,  et al.  Screening for major depressive disorder in children and adolescents: a systematic review for the US Preventive Services Task Force.   Ann Intern Med. 2016;164(5):342-349. doi:10.7326/M15-2259PubMedGoogle ScholarCrossref
10.
O’Connor  E , Gaynes  B , Burda  BU , Williams  C , Whitlock  EP . Screening for suicide risk in primary care: a systematic evidence review for the US Preventive Services Task Force. Agency for Healthcare Research and Quality; 2013.
11.
United Nations Development Programme. Human Development Report 2019: Beyond Income, Beyond Averages, Beyond Today: Inequalities in Human Development in the 21st Century. Published 2019. Accessed August 31, 2022. https://hdr.undp.org/content/human-development-report-2019
12.
Viswanathan  M , Kennedy  SM , McKeeman  J ,  et al.  Treatment of Depression in Children and Adolescents: A Systematic Review. AHRQ Comparative Effectiveness Review No. 224. Agency for Healthcare Research and Quality; 2020. AHRQ publication 20-EHC005-EF.
13.
Sterne  JAC , Savović  J , Page  MJ ,  et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials.   BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898PubMedGoogle ScholarCrossref
14.
Sterne  JA , Hernán  MA , Reeves  BC ,  et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.   BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919PubMedGoogle ScholarCrossref
15.
Whiting  P , Savović  J , Higgins  JP ,  et al; ROBIS Group.  ROBIS: a new tool to assess risk of bias in systematic reviews was developed.   J Clin Epidemiol. 2016;69:225-234. doi:10.1016/j.jclinepi.2015.06.005PubMedGoogle ScholarCrossref
16.
Whiting  PF , Rutjes  AW , Westwood  ME ,  et al; QUADAS-2 Group.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.   Ann Intern Med. 2011;155(8):529-536. doi:10.7326/0003-4819-155-8-201110180-00009PubMedGoogle ScholarCrossref
17.
Comprehensive Meta-analysis. Version 3. Biostat; 2013. Accessed September 16, 2022. https://www.meta-analysis.com/
18.
Deeks  J , Higgins  J , Altman  DG ; Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V, eds. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane. Published 2022. Accessed August 31, 2022. https://training.cochrane.org/handbook
19.
US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual: appendix VI: criteria for assessing internal validity of individual studies. Published 2017. Accessed August 16, 2022. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vi-criteria-assessing-internal-validity-individual-studies
20.
Viswanathan  M , Wallace  IF , Cook Middleton  J ,  et al.  Screening for anxiety in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force.   JAMA. Published October 11, 2022. doi:10.1001/jama.2022.16303Google Scholar
21.
Canals  J , Bladé  J , Carbajo  G , Domènech-Llabería  E .  The Beck Depression Inventory: psychometric characteristics and usefulness in nonclinical adolescents.   Eur J Psychol Assess. 2001;17(1):63-68. doi:10.1027//1015-5759.17.1.63Google ScholarCrossref
22.
Christensen  KS , Haugen  W , Sirpal  MK , Haavet  OR .  Diagnosis of depressed young people—criterion validity of WHO-5 and HSCL-6 in Denmark and Norway.   Fam Pract. 2015;32(3):359-363. doi:10.1093/fampra/cmv011PubMedGoogle ScholarCrossref
23.
Garrison  CZ , Addy  CL , Jackson  KL , McKeown  RE , Waller  JL .  The CES-D as a screen for depression and other psychiatric disorders in adolescents.   J Am Acad Child Adolesc Psychiatry. 1991;30(4):636-641. doi:10.1097/00004583-199107000-00017PubMedGoogle ScholarCrossref
24.
Johnson  JG , Harris  ES , Spitzer  RL , Williams  JBW .  The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients.   J Adolesc Health. 2002;30(3):196-204. doi:10.1016/S1054-139X(01)00333-0PubMedGoogle ScholarCrossref
25.
O’Connor  S , Ferguson  E , Carney  T , House  E , O’Connor  RC .  The development and evaluation of the Paediatric Index of Emotional Distress (PI-ED).   Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):15-26. doi:10.1007/s00127-015-1134-yPubMedGoogle ScholarCrossref
26.
Patton  GC , Coffey  C , Posterino  M , Carlin  JB , Wolfe  R , Bowes  G .  A computerised screening instrument for adolescent depression: population-based validation and application to a two-phase case-control study.   Soc Psychiatry Psychiatr Epidemiol. 1999;34(3):166-172. doi:10.1007/s001270050129PubMedGoogle ScholarCrossref
27.
Roberts  RE , Lewinsohn  PM , Seeley  JR .  Screening for adolescent depression: a comparison of depression scales.   J Am Acad Child Adolesc Psychiatry. 1991;30(1):58-66. doi:10.1097/00004583-199101000-00009PubMedGoogle ScholarCrossref
28.
Clarke  G , DeBar  LL , Pearson  JA ,  et al.  Cognitive behavioral therapy in primary care for youth declining antidepressants: a randomized trial.   Pediatrics. 2016;137(5):e20151851. doi:10.1542/peds.2015-1851PubMedGoogle ScholarCrossref
29.
Clarke  G , Debar  L , Lynch  F ,  et al.  A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication.   J Am Acad Child Adolesc Psychiatry. 2005;44(9):888-898. doi:10.1016/S0890-8567(09)62194-8PubMedGoogle ScholarCrossref
30.
Clarke  GN , Rohde  P , Lewinsohn  PM , Hops  H , Seeley  JR .  Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions.   J Am Acad Child Adolesc Psychiatry. 1999;38(3):272-279. doi:10.1097/00004583-199903000-00014PubMedGoogle ScholarCrossref
31.
Emslie  GJ , Ventura  D , Korotzer  A , Tourkodimitris  S .  Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.   J Am Acad Child Adolesc Psychiatry. 2009;48(7):721-729. doi:10.1097/CHI.0b013e3181a2b304PubMedGoogle ScholarCrossref
32.
Fristad  MA , Vesco  AT , Young  AS ,  et al.  Pilot randomized controlled trial of omega-3 and individual-family psychoeducational psychotherapy for children and adolescents with depression.   J Clin Child Adolesc Psychol. 2019;48(suppl 1):S105-S118. doi:10.1080/15374416.2016.1233500PubMedGoogle ScholarCrossref
33.
Luby  JL , Barch  DM , Whalen  D , Tillman  R , Freedland  KE .  A randomized controlled trial of parent-child psychotherapy targeting emotion development for early childhood depression.   Am J Psychiatry. 2018;175(11):1102-1110. doi:10.1176/appi.ajp.2018.18030321PubMedGoogle ScholarCrossref
34.
March  J , Silva  S , Petrycki  S ,  et al; Treatment for Adolescents with Depression Study (TADS) Team.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.   JAMA. 2004;292(7):807-820. doi:10.1001/jama.292.7.807PubMedGoogle ScholarCrossref
35.
Mufson  L , Dorta  KP , Wickramaratne  P , Nomura  Y , Olfson  M , Weissman  MM .  A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.   Arch Gen Psychiatry. 2004;61(6):577-584. doi:10.1001/archpsyc.61.6.577PubMedGoogle ScholarCrossref
36.
Richardson  LP , Ludman  E , McCauley  E ,  et al.  Collaborative care for adolescents with depression in primary care: a randomized clinical trial.   JAMA. 2014;312(8):809-816. doi:10.1001/jama.2014.9259PubMedGoogle ScholarCrossref
37.
Topooco  N , Berg  M , Johansson  S ,  et al.  Chat- and internet-based cognitive-behavioural therapy in treatment of adolescent depression: randomised controlled trial.   BJPsych Open. 2018;4(4):199-207. doi:10.1192/bjo.2018.18PubMedGoogle ScholarCrossref
38.
Topooco  N , Byléhn  S , Dahlström Nysäter  E ,  et al.  Evaluating the efficacy of internet-delivered cognitive behavioral therapy blended with synchronous chat sessions to treat adolescent depression: randomized controlled trial.   J Med Internet Res. 2019;21(11):e13393. doi:10.2196/13393PubMedGoogle ScholarCrossref
39.
Wagner  KD , Jonas  J , Findling  RL , Ventura  D , Saikali  K .  A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.   J Am Acad Child Adolesc Psychiatry. 2006;45(3):280-288. doi:10.1097/01.chi.0000192250.38400.9ePubMedGoogle ScholarCrossref
40.
Lindqvist  K , Mechler  J , Carlbring  P ,  et al.  Affect-focused psychodynamic internet-based therapy for adolescent depression: randomized controlled trial.   J Med Internet Res. 2020;22(3):e18047. doi:10.2196/18047PubMedGoogle ScholarCrossref
41.
Findling  RL , Robb  A , Bose  A .  Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.   J Child Adolesc Psychopharmacol. 2013;23(7):468-480. doi:10.1089/cap.2012.0023PubMedGoogle ScholarCrossref
42.
Hoyniak  CP , Whalen  DJ , Barch  D , Luby  JL .  Sleep problems in preschool-onset major depressive disorder: the effect of treatment with parent-child interaction therapy-emotion development.   Eur Child Adolesc Psychiatry. 2021;30(9):1463-1474. doi:10.1007/s00787-020-01641-1PubMedGoogle ScholarCrossref
43.
Curry  J , Rohde  P , Simons  A ,  et al; TADS Team.  Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).   J Am Acad Child Adolesc Psychiatry. 2006;45(12):1427-1439. doi:10.1097/01.chi.0000240838.78984.e2PubMedGoogle ScholarCrossref
44.
Emslie  G , Kratochvil  C , Vitiello  B ,  et al; Columbia Suicidality Classification Group; TADS Team.  Treatment for Adolescents with Depression Study (TADS): safety results.   J Am Acad Child Adolesc Psychiatry. 2006;45(12):1440-1455. doi:10.1097/01.chi.0000240840.63737.1dPubMedGoogle ScholarCrossref
45.
Kennard  B , Silva  S , Vitiello  B ,  et al; TADS Team.  Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).   J Am Acad Child Adolesc Psychiatry. 2006;45(12):1404-1411. doi:10.1097/01.chi.0000242228.75516.21PubMedGoogle ScholarCrossref
46.
Vitiello  B , Rohde  P , Silva  S ,  et al; TADS Team.  Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).   J Am Acad Child Adolesc Psychiatry. 2006;45(12):1419-1426. doi:10.1097/01.chi.0000242229.52646.6ePubMedGoogle ScholarCrossref
47.
McGlinchey  EL , Reyes-Portillo  JA , Turner  JB , Mufson  L .  Innovations in practice: the relationship between sleep disturbances, depression, and interpersonal functioning in treatment for adolescent depression.   Child Adolesc Ment Health. 2017;22(2):96-99. doi:10.1111/camh.12176PubMedGoogle ScholarCrossref
48.
Cipriani  A , Zhou  X , Del Giovane  C ,  et al.  Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.   Lancet. 2016;388(10047):881-890. doi:10.1016/S0140-6736(16)30385-3PubMedGoogle ScholarCrossref
49.
Thompson  EA , Eggert  LL .  Using the suicide risk screen to identify suicidal adolescents among potential high school dropouts.   J Am Acad Child Adolesc Psychiatry. 1999;38(12):1506-1514. doi:10.1097/00004583-199912000-00011PubMedGoogle ScholarCrossref
50.
Gould  MS , Marrocco  FA , Kleinman  M ,  et al.  Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial.   JAMA. 2005;293(13):1635-1643. doi:10.1001/jama.293.13.1635PubMedGoogle ScholarCrossref
51.
Robinson  J , Pan Yuen  H , Martin  C ,  et al.  Does screening high school students for psychological distress, deliberate self-harm, or suicidal ideation cause distress—and is it acceptable? an Australian-based study.   Crisis. 2011;32(5):254-263. doi:10.1027/0227-5910/a000087PubMedGoogle ScholarCrossref
52.
Asarnow  JR , Hughes  JL , Babeva  KN , Sugar  CA .  Cognitive-behavioral family treatment for suicide attempt prevention: a randomized controlled trial.   J Am Acad Child Adolesc Psychiatry. 2017;56(6):506-514. doi:10.1016/j.jaac.2017.03.015PubMedGoogle ScholarCrossref
53.
Cottrell  DJ , Wright-Hughes  A , Collinson  M ,  et al.  Effectiveness of systemic family therapy versus treatment as usual for young people after self-harm: a pragmatic, phase 3, multicentre, randomised controlled trial.   Lancet Psychiatry. 2018;5(3):203-216. doi:10.1016/S2215-0366(18)30058-0PubMedGoogle ScholarCrossref
54.
Cottrell  DJ , Wright-Hughes  A , Collinson  M ,  et al.  A pragmatic randomised controlled trial and economic evaluation of family therapy versus treatment as usual for young people seen after second or subsequent episodes of self-harm: the Self-Harm Intervention–Family Therapy (SHIFT) trial.   Health Technol Assess. 2018;22(12):1-222. doi:10.3310/hta22120PubMedGoogle ScholarCrossref
55.
Cottrell  DJ , Wright-Hughes  A , Eisler  I ,  et al.  Longer-term effectiveness of systemic family therapy compared with treatment as usual for young people after self-harm: an extended follow up of pragmatic randomised controlled trial.   EClinicalMedicine. 2020;18:100246. doi:10.1016/j.eclinm.2019.100246PubMedGoogle ScholarCrossref
56.
Diamond  GS , Wintersteen  MB , Brown  GK ,  et al.  Attachment-based family therapy for adolescents with suicidal ideation: a randomized controlled trial.   J Am Acad Child Adolesc Psychiatry. 2010;49(2):122-131. doi:10.1097/00004583-201002000-00006PubMedGoogle ScholarCrossref
57.
Green  JM , Wood  AJ , Kerfoot  MJ ,  et al.  Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation.   BMJ. 2011;342:d682. doi:10.1136/bmj.d682PubMedGoogle ScholarCrossref
58.
Griffiths  H , Duffy  F , Duffy  L ,  et al.  Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial.   BMC Psychiatry. 2019;19(1):167. doi:10.1186/s12888-019-2158-8PubMedGoogle ScholarCrossref
59.
Hazell  PL , Martin  G , Mcgill  K ,  et al.  Group therapy for repeated deliberate self-harm in adolescents: failure of replication of a randomized trial.   J Am Acad Child Adolesc Psychiatry. 2009;48(6):662-670. doi:10.1097/CHI.0b013e3181a0acecPubMedGoogle ScholarCrossref
60.
Hill  RM , Pettit  JW .  Pilot randomized controlled trial of LEAP: a selective preventive intervention to reduce adolescents’ perceived burdensomeness.   J Clin Child Adolesc Psychol. 2019;48(suppl 1):S45-S56. doi:10.1080/15374416.2016.1188705PubMedGoogle ScholarCrossref
61.
Hooven  C , Walsh  E , Pike  KC , Herting  JR .  Promoting CARE: including parents in youth suicide prevention.   Fam Community Health. 2012;35(3):225-235. doi:10.1097/FCH.0b013e318250bcf9PubMedGoogle ScholarCrossref
62.
King  CA , Klaus  N , Kramer  A , Venkataraman  S , Quinlan  P , Gillespie  B .  The Youth-Nominated Support Team–Version II for suicidal adolescents: a randomized controlled intervention trial.   J Consult Clin Psychol. 2009;77(5):880-893. doi:10.1037/a0016552PubMedGoogle ScholarCrossref
63.
King  CA , Arango  A , Kramer  A ,  et al; YST Study Team.  Association of the youth-nominated support team intervention for suicidal adolescents with 11- to 14-year mortality outcomes: secondary analysis of a randomized clinical trial.   JAMA Psychiatry. 2019;76(5):492-498. doi:10.1001/jamapsychiatry.2018.4358PubMedGoogle ScholarCrossref
64.
King  CA , Gipson  PY , Horwitz  AG , Opperman  KJ .  Teen options for change: an intervention for young emergency patients who screen positive for suicide risk.   Psychiatr Serv. 2015;66(1):97-100. doi:10.1176/appi.ps.201300347PubMedGoogle ScholarCrossref
65.
Mehlum  L , Tørmoen  AJ , Ramberg  M ,  et al.  Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial.   J Am Acad Child Adolesc Psychiatry. 2014;53(10):1082-1091. doi:10.1016/j.jaac.2014.07.003PubMedGoogle ScholarCrossref
66.
Mehlum  L , Ramberg  M , Tørmoen  AJ ,  et al.  Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up.   J Am Acad Child Adolesc Psychiatry. 2016;55(4):295-300. doi:10.1016/j.jaac.2016.01.005PubMedGoogle ScholarCrossref
67.
Mehlum  L , Ramleth  RK , Tørmoen  AJ ,  et al.  Long term effectiveness of dialectical behavior therapy versus enhanced usual care for adolescents with self-harming and suicidal behavior.   J Child Psychol Psychiatry. 2019;60(10):1112-1122. doi:10.1111/jcpp.13077PubMedGoogle ScholarCrossref
68.
Haga  E , Aas  E , Grøholt  B , Tørmoen  AJ , Mehlum  L .  Cost-effectiveness of dialectical behaviour therapy vs. enhanced usual care in the treatment of adolescents with self-harm.   Child Adolesc Psychiatry Ment Health. 2018;12:22. doi:10.1186/s13034-018-0227-2PubMedGoogle ScholarCrossref
69.
Ougrin  D , Boege  I , Stahl  D , Banarsee  R , Taylor  E .  Randomised controlled trial of therapeutic assessment versus usual assessment in adolescents with self-harm: 2-year follow-up.   Arch Dis Child. 2013;98(10):772-776. doi:10.1136/archdischild-2012-303200PubMedGoogle ScholarCrossref
70.
Ougrin  D , Zundel  T , Ng  A , Banarsee  R , Bottle  A , Taylor  E .  Trial of therapeutic assessment in London: randomised controlled trial of therapeutic assessment versus standard psychosocial assessment in adolescents presenting with self-harm.   Arch Dis Child. 2011;96(2):148-153. doi:10.1136/adc.2010.188755PubMedGoogle ScholarCrossref
71.
Pineda  J , Dadds  MR .  Family intervention for adolescents with suicidal behavior: a randomized controlled trial and mediation analysis.   J Am Acad Child Adolesc Psychiatry. 2013;52(8):851-862. doi:10.1016/j.jaac.2013.05.015PubMedGoogle ScholarCrossref
72.
Rossouw  TI , Fonagy  P .  Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial.   J Am Acad Child Adolesc Psychiatry. 2012;51(12):1304-1313. doi:10.1016/j.jaac.2012.09.018PubMedGoogle ScholarCrossref
73.
Tang  TC , Jou  SH , Ko  CH , Huang  SY , Yen  CF .  Randomized study of school-based intensive interpersonal psychotherapy for depressed adolescents with suicidal risk and parasuicide behaviors.   Psychiatry Clin Neurosci. 2009;63(4):463-470. doi:10.1111/j.1440-1819.2009.01991.xPubMedGoogle ScholarCrossref
74.
Wood  A , Trainor  G , Rothwell  J , Moore  A , Harrington  R .  Randomized trial of group therapy for repeated deliberate self-harm in adolescents.   J Am Acad Child Adolesc Psychiatry. 2001;40(11):1246-1253. doi:10.1097/00004583-200111000-00003PubMedGoogle ScholarCrossref
75.
Psychiatry & Behavioral Health Learning Network. Beck Depression Inventory-II (BDI-II). Published 1996. Accessed April 26, 2021. https://www.hmpgloballearningnetwork.com/site/pcn/saundras-corner/scales-screenersdepression/beck-depression-inventory-ii-bdi-ii
76.
Rinke  ML , Bundy  DG , Stein  REK ,  et al.  Increasing recognition and diagnosis of adolescent depression: Project RedDE: a cluster randomized trial.   Pediatr Qual Saf. 2019;4(5):e217. doi:10.1097/pq9.0000000000000217PubMedGoogle ScholarCrossref
77.
Aboustate  N , Raven  M , Klau  J , Jureidini  J .  Reanalysis of the Treatment for Adolescents with Depression Study (TADS) under the restoring invisible and abandoned trials initiative (RIAT).   BMJ Evid Based Med. 2019;24:A20-A21. doi:10.1136/bmjebm-2019-POD.42Google Scholar
78.
Doshi  P , Dickersin  K , Healy  D , Vedula  SS , Jefferson  T .  Restoring invisible and abandoned trials: a call for people to publish the findings.   BMJ. 2013;346:f2865. doi:10.1136/bmj.f2865PubMedGoogle ScholarCrossref
79.
US Food and Drug Administration. Suicidality in children and adolescents being treated with antidepressant medications. Published 2018. Accessed February 15, 2021. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications
80.
Hammad  TA , Laughren  T , Racoosin  J .  Suicidality in pediatric patients treated with antidepressant drugs.   Arch Gen Psychiatry. 2006;63(3):332-339. doi:10.1001/archpsyc.63.3.332PubMedGoogle ScholarCrossref
81.
Horowitz  LM , Bridge  JA , Teach  SJ ,  et al.  Ask Suicide-Screening Questions (ASQ): a brief instrument for the pediatric emergency department.   Arch Pediatr Adolesc Med. 2012;166(12):1170-1176. doi:10.1001/archpediatrics.2012.1276PubMedGoogle ScholarCrossref
82.
Aguinaldo  LD , Sullivant  S , Lanzillo  EC ,  et al.  Validation of the Ask Suicide-Screening Questions (ASQ) with youth in outpatient specialty and primary care clinics.   Gen Hosp Psychiatry. 2021;68:52-58. doi:10.1016/j.genhosppsych.2020.11.006PubMedGoogle ScholarCrossref
83.
The Joint Commission. Suicide prevention. Published 2021. Accessed August 16, 2022. https://www.jointcommission.org/resources/patient-safety-topics/suicide-prevention/
84.
National Institutes of Health. Ask Suicide-Screening Questions (ASQ) toolkit. Accessed August 16, 2022. https://www.nimh.nih.gov/research/research-conducted-at-nimh/asq-toolkit-materials
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close